Popular and talented actress Joyita Chatterjee, who’s well known in the entertainment space for projects like ‘Class Of 2020’, ‘Baal Veer’ and many others, has now finally recovered from Covid-19. Some time back, the actress had unfortunately tested Covid-19 positive amidst the rising number of cases in the country that brought her personal and professional life to a standstill. Finally, after having completed her medication, isolation and other recovery protocols, the talented actress has now recovered from COVID-19. It is to be noted that just before testing Covid-19, Joyita was gearing up for the shoot of her next, but her health unfortunately brought the schedule to hold. Now, after having recovered from the same, she is good enough to focus on her work, and that certainly makes her fans immensely happy. On being asked more about her recovery and what the challenges are that she’s facing as she’s finally resumed work, Joyita shares,
“It wasn’t easy by any means. The old fears of 2020 and 2021 haunted me throughout the entire recovery process. But all thanks to my doctor and the prayers of one and all, I am now finally Covid-free. Now that I have finally recovered, I have resumed my shoots and all pending commitments, and I am so glad that I could do that. While I have recovered and have tested negative for COVID-19 now, I can’t deny the fact that there’s still weakness that I can feel. However, being a professional and someone who adheres to commitments, I had to resume as soon as possible. It is indeed very challenging to resume work with weakness, but the drive and passion keep me going. Gratitude to the Almighty for giving me the strength to work despite weakness. Thankful to everyone who prayed for my speedy recovery.”
Kudos to Joyita for staying strong throughout the entire recovery process, and here’s hoping that she remains fit and healthy moving forward. On the work front, the actress has some exciting work developments taking place, and the official announcements will happen soon as per the ideal timelines. Stay tuned for more updates.